Embla Medical hf
CSE:EMBLA
Net Margin
Embla Medical hf
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IS |
|
Embla Medical hf
CSE:EMBLA
|
11.7B DKK |
8%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
223.1B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.3B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.2B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108B USD |
13%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
8%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.8B USD |
75%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
260.8B CNY |
33%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
23%
|
Embla Medical hf
Glance View
Embla Medical hf, a rising star in the medical device industry, has carved a niche in the sleep diagnostics sector with its innovative technology. Founded with the vision of transforming sleep health, the Iceland-based company specializes in developing advanced sleep diagnostic systems. These devices are crucial in identifying sleep disorders, a growing concern globally as awareness about sleep health continues to rise. Embla Medical’s flagship products are portable and user-friendly diagnostic tools that allow both clinicians and patients to monitor sleep patterns in real-time. By focusing on cutting-edge technology and accuracy, the company has established itself as a trusted partner in medical facilities worldwide, enhancing its reputation and solidifying its market presence. The business model of Embla Medical relies heavily on the research and development of its diagnostic systems, complemented by a strategic emphasis on customer service and support. The revenue stream is generated through the sale of these sophisticated devices to hospitals, sleep clinics, and directly to healthcare providers. Additionally, they offer ongoing maintenance services and software updates, providing a continuous source of income post-sale. By integrating software with hardware, they ensure that their equipment remains at the forefront of technological advancements in sleep diagnostics. This not only drives sales but also builds a loyal customer base that places high value on efficacy and ease of use. Embla Medical's focus on innovation and customer satisfaction positions them well to capitalize on the growing market for sleep healthcare solutions.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Embla Medical hf's most recent financial statements, the company has Net Margin of 8%.
You don't have any saved screeners yet